Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Firefly Neuroscience (AIFF) Short-Term Debt issuances (2021 - 2024)

Historic Short-Term Debt issuances for Firefly Neuroscience (AIFF) over the last 6 years, with Q2 2024 value amounting to -$200000.0.

  • Firefly Neuroscience's Short-Term Debt issuances changed N/A to -$200000.0 in Q2 2024 from the same period last year, while for Jun 2024 it was -$200000.0, marking a year-over-year decrease of 12000.0%. This contributed to the annual value of $575000.0 for FY2023, which is 3529.41% up from last year.
  • Per Firefly Neuroscience's latest filing, its Short-Term Debt issuances stood at -$200000.0 for Q2 2024.
  • Over the past 5 years, Firefly Neuroscience's Short-Term Debt issuances peaked at $575000.0 during Q1 2023, and registered a low of -$350000.0 during Q2 2021.
  • For the 4-year period, Firefly Neuroscience's Short-Term Debt issuances averaged around $190000.0, with its median value being $425000.0 (2022).